VistaGen Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Rotunno Mary L.
Mar 6 18:05 ET
VistaGen Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director GIN JERRY B
Mar 6 18:05 ET
VistaGen Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director FitzPatrick Margaret M
Mar 6 18:05 ET
VistaGen Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Curley Joanne
Mar 6 18:05 ET
VistaGen Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Cunningham Ann Michelle
Mar 6 18:05 ET
VistaGen Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SAXE JON S
Mar 6 18:05 ET
VistaGen Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Kenneth Griffin(5.8%),Citadel Advisors LLC(5.6%), etc.
Feb 14 18:23 ET
VistaGen Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Nantahala Capital Management, LLC(9.9%),Wilmot B. Harkey(9.9%), etc.
Feb 14 16:58 ET
VistaGen Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Great Point Partners, LLC(9.99%),Dr. Jeffrey R. Jay, M.D.(9.99%), etc.
Feb 14 16:46 ET
VistaGen Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Point72 Asset Management, L.P.(3.0%),Point72 Capital Advisors, Inc.(3.0%), etc.
Feb 14 08:57 ET
VistaGen Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-The Vanguard Group(6.79%)
Feb 13 22:30 ET
VistaGen Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Adler Reid G.
Jan 3 00:00 ET
VistaGen Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Singh Shawn
Jan 3 00:00 ET
VistaGen Therapeutics | 3: Initial statement of beneficial ownership of securities-Chief Operating Officer Prince Joshua S.
Nov 3, 2023 20:14 ET
VistaGen Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Chen Yu(9.9%),TCG Crossover GP II, LLC(7.5%), etc.
Oct 16, 2023 16:37 ET
VistaGen Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BVF Partners L.P.(9.99%),BVF Inc.(9.99%), etc.
Oct 16, 2023 16:34 ET
VistaGen Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Kenneth Griffin(5.7%),Citadel Advisors LLC(5.6%), etc.
Oct 16, 2023 16:01 ET
VistaGen Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Great Point Partners, LLC(9.99%),Dr. Jeffrey R. Jay, M.D.(9.99%), etc.
Oct 12, 2023 16:04 ET
VistaGen Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner COMMODORE CAPITAL LP
Oct 6, 2023 16:05 ET
VistaGen Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Commodore Capital LP(9.9%),Commodore Capital Master LP(9.9%)
Oct 6, 2023 16:05 ET
No Data
No Data